Epidemiology of ESBL in hospitals and in the community

Size: px
Start display at page:

Download "Epidemiology of ESBL in hospitals and in the community"

Transcription

1 Epidemiology of ESBL in hospitals and in the community Dietrich Mack Chair of Medical Microbiology and Infectious Diseases The School of Medicine - University of Wales Swansea P R I F Y S G O L C Y M R U A B E R T A W E U N I V E R S I T Y O F W A L E S S W A N S E A

2 Outbreak with Klebsiella pneumoniae (SHV-5) Location: Surgical ICU of university hospital with busy liver transplantation unit Patients: 11 Duration: Interventions: Termination: 5 months Contact isolation and single rooms without success Closure of ICU and dedication of a peripheral ward with specific health care personal for ESBLpatients

3 ESBL-positive strains detected in resistance studies of the Paul-Ehrlich-Gesellschaft 14 Percentage of ESBL-positive E. coli K. pneumoniae K. oytoca

4 Molecular types of ESBLs isolated in Hamburg CTX-M SHV TEM E. coli K. pneumoniae K. oxytoca All Stürenburg 2003 Diagn. Microbiol. Infect. Dis. 45:29

5 ESBL types in enterobacteria of multi-centre study Cologne, Heidelberg, Hamburg 2005 CTX-M SHV TEM E. coli K. pneumoniae K. oxytoca Enterobacter spp Proteus mirabilis 3-1 All Wiegand 2007 J Clin Microbiol 45:1167

6 ESBL resistance mechanisms among cephalosporin-resistant Enterobacteriaceae in London and South-East England 2004 Species N CTX-M (%) Other ESBL (%) AmpC (%) Escherichia coli (50.7) 88 (15.3) 41 (7.1) Klebsiella spp (81.5) 24 (9.9) 1 Enterobacter spp (4.0) 26 (12.9) 90 (44.8) Estimate 2.5% of all E. coli isolates are cephalosporin resistant; 1.1% of all carry CTX-M enzymes 9.7% of all Klebsiella spp. isolates are cephalosporin resistant; 7.6% of all carry CTX-M or other ESBL Potz 2006 JAC 58:320

7 Emergence of CTX-M-positive Enterobacteriaceae in Austria Percentage of CTX-M-positive strains E. coli Klebsiella spp. Eisner et al 2006 AAC 50:785

8 Trends in production of ESBLs among Enterobacteriaceae in Italy Inpatients Outpatients % Total In species Total In species Total In species Escherichia coli Proteus mirabilis Providencia stuartii Klebsiella pneu Klebsiella oxytoca Enterobacter aerog Luzzaro 2006 JCM

9 Long-term study of ESBL epidemiology in Escherichia coli in Sevilla, Spain Romero 2005 CMI 11:625

10 Dissemination of CTX-M type ESBL in Enterobacteriaceae in People s Republic of China Munday 2004 Int J Antimicrob Agents 23:175

11 Characteristics of CTX-M producing E. coli in the Calgary Health Region 2000 to 2005 Pitout 2007 AAC 51:1281

12 Epidemiology of CTX-M-producing Escherichia coli strains in the UK 2003/2004 Woodford 2004 JAC 54:735

13 Distribution of episodes of bacteraemia due to ESBL-producing Escherichia coli Rodriguez-Bano 2006 CID 43:1409

14 Number of ESBL-positive E. coli and Klebsiella spp. bacteraemia cases Number of bacteraemic episodes % 26.5% 0.5% 22.6% E. coli Klebsiella spp.

15 Proportion of community-onset and hospitalacquired episodes of ESBL-positive E. coli and Klebsiella spp. bacteraemia Number of ESBL-positive episodes % 26.6% 22.2% CA HAI

16 Risk factors for blood stream infection with ESBL-positive E. coli and Klebsiella spp. OR P value Prior ß-lactam antibiotics Other antibiotics Prior admission to ICU Length of hospital stay > 15 d Skippen et al J Hosp Infect 64:115

17 Community-onset urinary tract infection caused by CTX-M-positive Escherichia coli in Truro, Cornwall 69 resistant E. coli strains submitted to reference laboratory during Clonal typing identified CTX-M-group 1 positive outbreak strain different from UK epidemic strain A (CTX-M-15) Cornish outbreak strain caused hospital acquired blood stream infection (patient 1) and mostly community-onset UTI Most patients had hospital contact during the preceding 3 months during period of admission of patient 1 Woodford 2004 JAC 54:735

18 Independent risk factors for community acquired ESBL-positive urinary tract infections Risk factor OR 95% CI Previous hospitalisation < 3 mo Antibiotic treatment < 3 mo Age > 60 yr Diabetes Male gender Klebsiella pneumoniae infection Previous use of 2nd gen ceph Previous use of 3rd gen ceph Previous use of quinolones Previous use of penicillin Colodner 2004 Eur J Clin Microbiol Infect Dis 23:163

19 Faecal carriage of ESBL positive Enterobacteriaceae England % Spain 2001/ % 7.5% Spain % 0.7% % % Munday et al JAC 54:628 Miro 2005 JAC 56:1152 Valverde 2004 JCM 42:4769

20 Persistent recovery of ESBL-positive Escherichia coli with CTX-M-14/17 and TEM-35 from farm animals in Wales Liebana et al 2006 JCM 44:1630

21 Escherichia coli producing CTX-M ESBLs in food animals in Hong Kong Pigs (n=300) 6 (2%) CTX-M-14, CTX-M-3, CTX-M24 Cattle (n=96) 3 (3.1%) CTX-M-13, Pigeons (n=33) 1 (3%) CTX-M-14 Chicken (n=243) 0 Geese (n=32) 0 Ducks (n=30) 0 Duan 2006 Microb Drug Resist 12:145

22 Isolation of CTX-M ESBL positive Escherichia coli from raw chicken meat sold in the West Midlands, United Kingdom British 1/62 CTX-M-1 Irish 0/3 Brazil 5/10 CTX-M-2 Brazil/Poland/France 3/4 CTX-M-2 Poland 0/4 Netherlands 2/2 CTX-M-2 E/F/DK/D 0/4 Unknown 6/40 CTX-M-2, 8, 14 Total 17/129 (13.2%) Ensor, Warren, et al Poster 1025, 17th ECCMID, Munich

23 Community-acquired bacteraemia with ESBL-carrying Enterobacteriaceae 80 episodes of non-nosocomial bacteraemia 11/80 ESBL: 3 community acquired; 8 health care associated ESBL: 8% E. coli; 25% Klebsiella spp., 20% Proteus mirabilis Admission from nursing home risk factor (OR 4.76, P=.001) 10.8% patients admission faecal carriage of ESBL organism 15.4% of colonised patients developed bacteraemia due to CAZ-resistant organism during hospitalisation (OR 38.9; P<.001) 73% of community-acquired organisms carried CTX-M ESBLs Ben-Ami 2006 CID 42:925

24 Distribution of ESBL-positive Escherichia coli in long-term care facilities in Belfast area A. Loughrey, P. Rooney, M. O'Leary, M. McCalmont, M. Warner, E. Karisik, P. Donaghy, B. Smyth, N. Woodford, D. Livermore 2007 Poster 17th ECCMID Munich

25 Conclusions CTX-M ESBL predominate in many parts of the world Infections with ESBL-carrying Enterobacteriaceae tend to originate increasingly in the community Carriage rate for ESBL-positive Enterobacteriaceae may be substantial, but more data needed Colonisation of nursing home residents appears to exceptionally high in some places ESBL-positive Enterobacteriaceae are found in food animals

26 Collaborators Angharad P. Davies Llinos Harris Caron Jones Naledi Bome Irith Wiegand Enno Stürenburg Harald Seifert Heinrich K. Geiss Khalid El-Bouri Ann M. Lewis Nidhika Berry EU ESF Fund Wyeth

PROFESSOR PETER M. HAWKEY

PROFESSOR PETER M. HAWKEY Multi-drug resistant Escherichia coli PROFESSOR PETER M. HAWKEY School of Immunity and Infection College of Medical and Dental Sciences University of Birmingham Birmingham B15 2TT Health Protection Agency

More information

Expert rules. for Gram-negatives

Expert rules. for Gram-negatives Academic Perspective in Expert rules Emerging Issues of Resistance in Gram-ve Bacteria for Gram-negatives Trevor Winstanley Sheffield Teaching Hospitals Presented on behalf of David Livermore University

More information

Carbapenemases in Enterobacteriaceae: Prof P. Nordmann Bicêtre hospital, South-Paris Med School

Carbapenemases in Enterobacteriaceae: Prof P. Nordmann Bicêtre hospital, South-Paris Med School Carbapenemases in Enterobacteriaceae: 2012 Prof P. Nordmann Bicêtre hospital, South-Paris Med School March 21, 2012 Trends in Molecular Medecine NDM IMP OXA-48 KPC VIM ALERT VI M KPC KPC NDM I MP OXA-

More information

Overcoming the PosESBLities of Enterobacteriaceae Resistance

Overcoming the PosESBLities of Enterobacteriaceae Resistance Overcoming the PosESBLities of Enterobacteriaceae Resistance Review of current treatment options Jamie Reed, PharmD Pharmacy Grand Rounds August 28, 2018 Rochester, MN 2018 MFMER slide-1 Disclosure No

More information

β-lactamase inhibitors

β-lactamase inhibitors β-lactamase inhibitors Properties, microbiology & enzymology DAVID M LIVERMORE Professor of Medical Microbiology, UEA Lead on Antibiotic Resistance, Public Health England β-lactamase classes A B C D Serine

More information

jmb Research Article Review Semi Kim 1, Ji Youn Sung 2, Hye Hyun Cho 3, Kye Chul Kwon 1, and Sun Hoe Koo 1 *

jmb Research Article Review Semi Kim 1, Ji Youn Sung 2, Hye Hyun Cho 3, Kye Chul Kwon 1, and Sun Hoe Koo 1 * J. Microbiol. Biotechnol. (2014), 24(6), 765 770 http://dx.doi.org/10.4014/jmb.1306.06036 Review Research Article jmb Characterization of CTX-M-14- and CTX-M-15-Producing Escherichia coli and Klebsiella

More information

Expert rules in antimicrobial susceptibility testing: State of the art

Expert rules in antimicrobial susceptibility testing: State of the art Expert rules in antimicrobial susceptibility testing: State of the art ESCMID Postgraduate Education Course Antimicrobial Susceptibility Testing and Surveillance: from Laboratory to Clinic Hospital Universitario

More information

Molecular characterisation of CTX-M-type extendedspectrum β-lactamases of Escherichia coli isolated from a Portuguese University Hospital

Molecular characterisation of CTX-M-type extendedspectrum β-lactamases of Escherichia coli isolated from a Portuguese University Hospital EJHP Science Volume 17 2011 Issue 3 P. 1-5 2011 Pharma Publishing and Media Europe. All rights reserved 1781-7595 25 www.ejhp.eu Molecular characterisation of CTX-M-type extendedspectrum β-lactamases of

More information

Determining the Optimal Carbapenem MIC that Distinguishes Carbapenemase-Producing

Determining the Optimal Carbapenem MIC that Distinguishes Carbapenemase-Producing AAC Accepted Manuscript Posted Online 8 August 2016 Antimicrob. Agents Chemother. doi:10.1128/aac.00838-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 1 2 Determining the

More information

Academic Perspective in. David Livermore Prof of Medical Microbiology, UEA Lead on Antibiotic resistance PHE

Academic Perspective in. David Livermore Prof of Medical Microbiology, UEA Lead on Antibiotic resistance PHE Academic Perspective in Emerging No, we can t Issues treat of carbapenemase Resistance and ESBL in Gram-ve producers Bacteria based on MIC David Livermore Prof of Medical Microbiology, UEA Lead on Antibiotic

More information

Enterobacteriaceae with acquired carbapenemases, 2015

Enterobacteriaceae with acquired carbapenemases, 2015 Enterobacteriaceae with acquired carbapenemases, 2015 Background The acquired or transferable (as opposed to chromosomally encoded) carbapenemases found in Enterobacteriaceae belong to three of the four

More information

Update on CLSI and EUCAST

Update on CLSI and EUCAST Update on CLSI and EUCAST 1 Completed work» Cephalosporin breakpoints for Enterobacteriaceae ESBL screens MIC versus resistance mechanism» Carbapenem breakpoints for Enterobacteriaceae Modified Hodge Test»

More information

Public Health Surveillance for Multi Drug Resistant Organisms in Orange County

Public Health Surveillance for Multi Drug Resistant Organisms in Orange County Public Health Surveillance for Multi Drug Resistant Organisms in Orange County Matt Zahn, MD Medical Director Epidemiology and Assessment Orange County Public Health Antimicrobial Mechanisms of Action

More information

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); July 2014.

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); July 2014. Annual survey of extended-spectrum -lactamase (ESBL)-producing Enterobacteriaceae, 2013 Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research

More information

breakpoints, cephalosporins, CLSI, Enterobacteriacae, EUCAST, review Clin Microbiol Infect 2008; 14 (Suppl. 1):

breakpoints, cephalosporins, CLSI, Enterobacteriacae, EUCAST, review Clin Microbiol Infect 2008; 14 (Suppl. 1): REVIEW Breakpoints for intravenously used cephalosporins in Enterobacteriaceae EUCAST and CLSI breakpoints G. Kahlmeter Department of Clinical Microbiology, Central Hospital, Växjö, Sweden ABSTRACT It

More information

Epidemiology of the β-lactamase resistome among Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae in the Chicago region

Epidemiology of the β-lactamase resistome among Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae in the Chicago region Epidemiology of the β-lactamase resistome among Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae in the Chicago region Michael Y. Lin MD MPH 1, Karen Lolans BS 1, Rosie D. Lyles,

More information

Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum b-lactamases in the UK

Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum b-lactamases in the UK Journal of Antimicrobial Chemotherapy Advance Access published January 25, 2008 Journal of Antimicrobial Chemotherapy doi:10.1093/jac/dkm517 Imported chicken meat as a potential source of quinolone-resistant

More information

A new diagnostic microarray (Check-KPC ESBL) for detection and. identification of extended-spectrum beta-lactamases in highly resistant

A new diagnostic microarray (Check-KPC ESBL) for detection and. identification of extended-spectrum beta-lactamases in highly resistant JCM Accepts, published online ahead of print on 8 June 2011 J. Clin. Microbiol. doi:10.1128/jcm.02087-10 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital

Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital ISSN: 2319-7706 Volume 3 Number 10 (2014) pp. 474-478 http://www.ijcmas.com Original Research Article Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital

More information

Reporting blood culture results to clinicians: MIC, resistance mechanisms, both?

Reporting blood culture results to clinicians: MIC, resistance mechanisms, both? Reporting blood culture results to clinicians: MIC, resistance mechanisms, both? Christian G. Giske, MD, PhD Senior Consultant Physician/Associate Professor Department of Clinical Microbiology Karolinska

More information

Emergence of non-kpc carbapenemases: NDM and more

Emergence of non-kpc carbapenemases: NDM and more Emergence of non-kpc carbapenemases: NDM and more --- David Livermore Health Protection Agency, UK The first acquired carbapenemase to be recognised in gram-negative bacteria was IMP-1, a metallo-type,

More information

Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by MALDI- TOF mass spectrometry

Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by MALDI- TOF mass spectrometry JCM Accepts, published online ahead of print on 2 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.01002-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 11 12

More information

Healthcare-associated infections acquired in intensive care units

Healthcare-associated infections acquired in intensive care units SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Healthcare-associated infections acquired in intensive care units Key facts In 2015, 11 788 (8.3%) of patients staying in an intensive care unit

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author www.eucast.org EXPERT RULES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA Departamento de Microbiología II Universidad

More information

Global Epidemiology of Carbapenem- Resistant Enterobacteriaceae (CRE)

Global Epidemiology of Carbapenem- Resistant Enterobacteriaceae (CRE) Global Epidemiology of Carbapenem- Resistant Enterobacteriaceae (CRE) Mitchell J. Schwaber, MD MSc Director, National Center for Infection Control Ministry of Health State of Israel November 27, 2012 1

More information

Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong. Title. Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH

Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong. Title. Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH Title Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong Author(s) Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH Citation International Journal Of Antimicrobial Agents, 2011, v. 37 n. 4, p.

More information

Other antimicrobials of interest in the era of extended-spectrum b-lactamases: fosfomycin, nitrofurantoin and tigecycline

Other antimicrobials of interest in the era of extended-spectrum b-lactamases: fosfomycin, nitrofurantoin and tigecycline REVIEW Other antimicrobials of interest in the era of extended-spectrum b-lactamases: fosfomycin, nitrofurantoin and tigecycline J. Garau Department of Medicine, Hospital Mutua de Terrassa, University

More information

Received 31 January 2011/Returned for modification 2 March 2011/Accepted 15 March 2011

Received 31 January 2011/Returned for modification 2 March 2011/Accepted 15 March 2011 JOURNAL OF CLINICAL MICROBIOLOGY, May 2011, p. 1965 1969 Vol. 49, No. 5 0095-1137/11/$12.00 doi:10.1128/jcm.00203-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Comparative

More information

Disclosure. Objectives. Evolution of β Lactamases. Extended Spectrum β Lactamases: The New Normal. Prevalence of ESBL Mystic Program

Disclosure. Objectives. Evolution of β Lactamases. Extended Spectrum β Lactamases: The New Normal. Prevalence of ESBL Mystic Program 47 th Annual Meeting August 2-4, 2013 Orlando, FL Extended Spectrum β Lactamases: The New Normal Disclosure I do have a vested interest in or affiliation with the following companies or organizations Triax

More information

Enterobacteriaceae with acquired carbapenemases, 2016

Enterobacteriaceae with acquired carbapenemases, 2016 Enterobacteriaceae with acquired carbapenemases, 2016 Background The acquired or transferable (as opposed to chromosomally encoded) carbapenemases found in Enterobacteriaceae belong to three of the four

More information

Infectious Disease Testing. UriSelect 4 Medium. Direct Identification Visibly Reliable

Infectious Disease Testing. UriSelect 4 Medium. Direct Identification Visibly Reliable Infectious Disease Testing Urielect 4 Medium Direct Identification Visibly Reliable Urielect 4 Non selective chromogenic medium for the isolation, differentiation and enumeration of urinary tract infections

More information

Carbapenem-resistant Enterobacteriaceae (CRE): Coming to a hospital near you?

Carbapenem-resistant Enterobacteriaceae (CRE): Coming to a hospital near you? Carbapenem-resistant Enterobacteriaceae (CRE): Coming to a hospital near you? Jon Otter, PhD FRCPath Imperial College Healthcare NHS Trust www.reflectionsipc.com @jonotter Contents What s the problem?

More information

REVIEW. Hospital, Shrewsbury, Shropshire and 2 Shropshire and Staffordshire Health Protection Unit, Health Protection Agency, UK

REVIEW. Hospital, Shrewsbury, Shropshire and 2 Shropshire and Staffordshire Health Protection Unit, Health Protection Agency, UK REVIEW Control of infections due to extended-spectrum b-lactamase-producing organisms in hospitals and the community R. E. Warren 1, G. Harvey 1, R. Carr 2, D. Ward 2 and A. Doroshenko 2 1 Department of

More information

Carbapenemase-producing Enterobacteriaceae

Carbapenemase-producing Enterobacteriaceae Carbapenemase-producing Enterobacteriaceae 2012 CNR Associé Résistance aux Antibiotiques Prof. P. Nordmann Carbapenemases in Enterobacteriaceae May, 2012 Penicillins Cephalosporins Carbapenems Extended-spectrum

More information

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Carbapenem-resistant Enterobacteriaceae

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Carbapenem-resistant Enterobacteriaceae GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 47: Carbapenem-resistant Enterobacteriaceae Authors E-B Kruse, MD H. Wisplinghoff, MD Chapter Editor Michelle Doll, MD, MPH) Topic Outline Key Issue Known

More information

Lane CR, Kwong JC, Romanes F, Easton M, Cronin K, Waters MJ, Stevens K, Schultz MB, Sherry NL, Tai A, Ballard SA, Seemann T, Stinear T & Howden BP

Lane CR, Kwong JC, Romanes F, Easton M, Cronin K, Waters MJ, Stevens K, Schultz MB, Sherry NL, Tai A, Ballard SA, Seemann T, Stinear T & Howden BP Combined genomic and epidemiological investigation of a state-wide outbreak of KPCproducing Enterobacteriaceae Lane CR, Kwong JC, Romanes F, Easton M, Cronin K, Waters MJ, Stevens K, Schultz MB, Sherry

More information

Clinical significance of extended-spectrum

Clinical significance of extended-spectrum Clinical significance of extended-spectrum β-lactamases Expert Rev. Anti Infect. Ther. 6(5), 671 683 (2008) Jesús Rodríguez-Baño and Alvaro Pascual Author for correspondence Sección de Enfermedades Infecciosas,

More information

Outpatient treatment in women with acute pyelonephritis after visiting emergency department

Outpatient treatment in women with acute pyelonephritis after visiting emergency department LETTER TO THE EDITOR Korean J Intern Med 2017;32:369-373 Outpatient treatment in women with acute pyelonephritis after visiting emergency department Hee Kyoung Choi 1,*, Jin-Won Chung 2, Won Sup Oh 3,

More information

In Vitro Activity of Ceftazidime-Avibactam Against Isolates. in a Phase 3 Open-label Clinical Trial for Complicated

In Vitro Activity of Ceftazidime-Avibactam Against Isolates. in a Phase 3 Open-label Clinical Trial for Complicated AAC Accepted Manuscript Posted Online 21 November 2016 Antimicrob. Agents Chemother. doi:10.1128/aac.01820-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10

More information

Use of Faropenem as an Indicator of Carbapenemase Activity

Use of Faropenem as an Indicator of Carbapenemase Activity JCM Accepts, published online ahead of print on 10 April 2013 J. Clin. Microbiol. doi:10.1128/jcm.00720-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 Use of Faropenem as

More information

Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version th September 2010

Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version th September 2010 Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the

More information

Burns outbreaks - the UHB experience

Burns outbreaks - the UHB experience Burns outbreaks - the UHB experience Dr Mark Garvey Principal Clinical Scientist in Microbiology Director of the Hospital Infection Research Laboratory Associate Director of Infection Prevention and Control

More information

CTX-M: changing the face of ESBLs in Europe

CTX-M: changing the face of ESBLs in Europe Journal of Antimicrobial Chemotherapy (2007) 59, 165 174 doi:10.1093/jac/dkl483 Advance Access publication 6 December 2006 CTX-M: changing the face of ESBLs in Europe David M. Livermore 1 *, Rafael Canton

More information

Faecal carriage of extended-spectrum b-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology

Faecal carriage of extended-spectrum b-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology Journal of Antimicrobial Chemotherapy (2008) 62, 1142 1149 doi:10.1093/jac/dkn293 Advance Access publication 18 July 2008 Faecal carriage of extended-spectrum b-lactamase-producing Escherichia coli: prevalence,

More information

The Year in Infection Control

The Year in Infection Control The Year in Infection Control Andie Lee Departments of Infectious Diseases and Microbiology Royal Prince Alfred Hospital Sydney, Australia 1 1.223 million Pubmed publications last 12 months 2 Selection

More information

10/4/16. mcr-1. Emerging Resistance Updates. Objectives. National Center for Emerging and Zoonotic Infectious Diseases. Alex Kallen, MD, MPH, FACP

10/4/16. mcr-1. Emerging Resistance Updates. Objectives. National Center for Emerging and Zoonotic Infectious Diseases. Alex Kallen, MD, MPH, FACP National Center for Emerging and Zoonotic Infectious Diseases Emerging Resistance Updates Alex Kallen, MD, MPH, FACP Lead Antimicrobial Resistance and Emerging Pathogens Team Prevention and Response Branch

More information

Educational Workshops 2016

Educational Workshops 2016 Educational Workshops 2016 Keynote CPE Screening We are grateful to Dr Andrew Dodgson, Consultant Microbiologist, Public Health England and Central Manchester Hospitals NHS Foundation Trust Terminology

More information

HSE co-ordination of UK response to recasting of Euratom directives. Pandemic (H1N1) 2009 influenza: UK situation at 20 August 2009

HSE co-ordination of UK response to recasting of Euratom directives. Pandemic (H1N1) 2009 influenza: UK situation at 20 August 2009 Volume 3 Number 33 Published on: 21 August 2009 Current News Update on rabies free status of France, August 2009 HSE co-ordination of UK response to recasting of Euratom directives Pandemic (H1N1) 2009

More information

Healthcare-associated infection: what the impact is and where the burden falls

Healthcare-associated infection: what the impact is and where the burden falls Healthcare-associated infection: what the impact is and where the burden falls E. Tacconelli Dept. Infectious Diseases Catholic University, Rome, Italy Road map Incidence Mortality Lenght of hospitalisation

More information

Received 24 July 2009; returned 28 August 2009; revised 9 October 2009; accepted 17 October 2009

Received 24 July 2009; returned 28 August 2009; revised 9 October 2009; accepted 17 October 2009 J Antimicrob Chemother 2010; 65: 333 341 doi:10.1093/jac/dkp411 Advance publication 3 December 2009 Bacteraemia due to extended-spectrum b-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients:

More information

JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1998, p Vol. 36, No. 9. Copyright 1998, American Society for Microbiology. All Rights Reserved.

JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1998, p Vol. 36, No. 9. Copyright 1998, American Society for Microbiology. All Rights Reserved. JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1998, p. 2575 2579 Vol. 36, No. 9 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Can Results Obtained with Commercially

More information

Guess or get it right?

Guess or get it right? Guess or get it right? Antimicrobial prescribing in the 21 st century Robert Masterton Traditional Treatment Paradigm Conservative start with workhorse antibiotics Reserve more potent drugs for non-responders

More information

Evaluation of CHROMagar msupercarba for the detection of carbapenemaseproducing Gram-negative organisms

Evaluation of CHROMagar msupercarba for the detection of carbapenemaseproducing Gram-negative organisms ORIGINAL ARTICLE Evaluation of CHROMagar msupercarba for the detection of carbapenemaseproducing Gram-negative organisms Julie Creighton and Hui Wang Canterbury Health Laboratories, Christchurch ABSTRACT

More information

Sensitivity of Surveillance Testing for Multidrug-Resistant Gram-Negative Bacteria in the

Sensitivity of Surveillance Testing for Multidrug-Resistant Gram-Negative Bacteria in the JCM Accepts, published online ahead of print on 20 August 2014 J. Clin. Microbiol. doi:10.1128/jcm.02369-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 Sensitivity of Surveillance

More information

Carbapenem Disks on MacConkey agar as screening methods for the detection of. Carbapenem-Resistant Gram negative rods in stools.

Carbapenem Disks on MacConkey agar as screening methods for the detection of. Carbapenem-Resistant Gram negative rods in stools. JCM Accepts, published online ahead of print on 7 November 2012 J. Clin. Microbiol. doi:10.1128/jcm.02878-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Carbapenem Disks

More information

Benefits of the pneumococcal immunisation programme in children in the United Kingdom

Benefits of the pneumococcal immunisation programme in children in the United Kingdom Benefits of the pneumococcal immunisation programme in children in the United Kingdom 2006-2014 Professor Mary P E Slack mpeslack@gmail.com March 2015 Disclosure of interest The presenter has received

More information

Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011.

Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011. Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011. Sophie Vaux, Anne Carbonne, Jean-Michel Thiolet, Vincent Jarlier, Bruno Coignard, the RAISIN and Expert Laboratories Group

More information

Surveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia

Surveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia Feb. 2016 THE JAPANESE JOURNAL OF ANTIBIOTICS 69 1 41 41 Surveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia IRINA

More information

Rate of Transmission of Extended-Spectrum

Rate of Transmission of Extended-Spectrum MAJOR ARTICLE Rate of Transmission of Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae Without Contact Isolation Sarah Tschudin-Sutter, 1 Reno Frei, 2 Marc Dangel, 1 Anne Stranden, 1 and Andreas

More information

Spread of carbapenems resistant Enterobacteriaceae in South Africa; report from National Antimicrobial Resistance Reference Laboratory

Spread of carbapenems resistant Enterobacteriaceae in South Africa; report from National Antimicrobial Resistance Reference Laboratory Spread of carbapenems resistant Enterobacteriaceae in South Africa; report from National Antimicrobial Resistance Reference Laboratory Olga Perovic*, Ashika Singh-Moodley, Samantha Iyaloo 5 th November

More information

Distribution of TEM, SHV and CTX-M Genes among ESBL-producing Enterobacteriaceae isolates in Iran

Distribution of TEM, SHV and CTX-M Genes among ESBL-producing Enterobacteriaceae isolates in Iran African Journal of Microbiology Research Vol. 6(26), pp. 5433-5439, 12 July, 2012 Available online at http://www.academicjournals.org/ajmr DOI: 10.5897/AJMR11.017 ISSN 1996-0808 2012 Academic Journals

More information

Clinical Microbiology Newsletter

Clinical Microbiology Newsletter Clinical Microbiology Newsletter $88 Vol. 30, No. 10 www.cmnewsletter.com May 15, 2008 Newer β-lactamases: Clinical and Laboratory Implications, Part I * Ellen Smith Moland, B.S.M.T., Soo-Young Kim, M.D.,

More information

Perspectives on emerging multidrug resistant organisms in the pediatric setting

Perspectives on emerging multidrug resistant organisms in the pediatric setting Perspectives on emerging multidrug resistant organisms in the pediatric setting Ombeva Malande Vaccinologist/Paed infectious diseases Specialist Lecturer Makerere/Egerton University 27 th April 2018; 18th

More information

Cefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010

Cefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010 Cefotaxime Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the European

More information

High diversity of extended-spectrum b-lactamases among clinical isolates of Enterobacteriaceae from Portugal

High diversity of extended-spectrum b-lactamases among clinical isolates of Enterobacteriaceae from Portugal Journal of Antimicrobial Chemotherapy Advance Access published October 3, 2007 Journal of Antimicrobial Chemotherapy doi:10.1093/jac/dkm381 High diversity of extended-spectrum b-lactamases among clinical

More information

Enterobacteriaceae in Bamako, Mali. Laboratoire de Bactériologie-Virologie-Hygiène Hospitalière, CHU Reims, UFR Médecine

Enterobacteriaceae in Bamako, Mali. Laboratoire de Bactériologie-Virologie-Hygiène Hospitalière, CHU Reims, UFR Médecine AAC Accepts, published online ahead of print on 31 August 2009 Antimicrob. Agents Chemother. doi:10.1128/aac.00675-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions.

More information

The Public Health Benefit of CRE Colonization Testing

The Public Health Benefit of CRE Colonization Testing The Public Health Benefit of CRE Colonization Testing Allison C Brown, PhD MPH Team Lead, AR Capacities and Special Studies Division of Healthcare Quality Promotion CDC Carbapenem Resistance Serious threat

More information

ST11 KPC-2 Klebsiella pneumoniae detected in Taiwan

ST11 KPC-2 Klebsiella pneumoniae detected in Taiwan AAC Accepts, published online ahead of print on 30 January 2012 Antimicrob. Agents Chemother. doi:10.1128/aac.05576-11 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5

More information

Results and experience of BARN ESBL project. Marina Ivanova and project team Tallinn

Results and experience of BARN ESBL project. Marina Ivanova and project team Tallinn Results and experience of BARN ESBL project Marina Ivanova and project team Tallinn 13.05.2013 Aim of the project Improvement of detection and surveillance of resistance caused by extended spectrum betalactamase

More information

Analysis of the common opportunistic pathogens

Analysis of the common opportunistic pathogens 2009 12 4 4 Journal of Microbes and Infection, December 2009, Vol. 4, No. 4 241 1, 3 1, 2, 3, 1. ( ), 201508; 2., 200040; 3., 200032 :,,,,,,, ;, : ; ; Analysis of the common opportunistic pathogens SUN

More information

KPC around the world Maria Virginia Villegas, MD, MSC

KPC around the world Maria Virginia Villegas, MD, MSC KPC around the world Maria Virginia Villegas, MD, MSC Scientific Director Bacterial Resistance and Nosocomial Infections Research Area International Center for Medical Research and Training, CIDEIM, Cali,

More information

J. E. DEGENER, A. C. W. SMIT, M. F. MICHEL H. A. VALKENBURG* AND L. MULLER*

J. E. DEGENER, A. C. W. SMIT, M. F. MICHEL H. A. VALKENBURG* AND L. MULLER* J. MED. MICROBIOL.-VOL. 16 (1983), 139-145 0 1983 The Pathological Society of Great Britain and Ireland FAECAL CARRIAGE OF AEROBIC GRAM-NEGATIVE BACILLI AND DRUG RESISTANCE OF ESCHERZCHZA COLZ IN DIFFERENT

More information

Sepsis Treatment: Early Identification Remains the Key Issue

Sepsis Treatment: Early Identification Remains the Key Issue Sepsis Treatment: Early Identification Remains the Key Issue Marin H. Kollef, MD Professor of Medicine Washington University School of Medicine Director, Medical Critical Care Director, Respiratory Care

More information

Rapid identification of emerging resistance in Gram negatives. Prof. Patrice Nordmann

Rapid identification of emerging resistance in Gram negatives. Prof. Patrice Nordmann Rapid identification of emerging resistance in Gram negatives Prof. Patrice Nordmann Emerging Resistance threats, CDC USA-2013 Enterobacteriaceae producing extendedspectrum β-lactamases (ESBL) Multi-resistant

More information

Strain-specific transmission in an outbreak of ESBL-producing Enterobacteriaceae in the hemato-oncology care unit: a cohort study

Strain-specific transmission in an outbreak of ESBL-producing Enterobacteriaceae in the hemato-oncology care unit: a cohort study Uemura et al. BMC Infectious Diseases (2017) 17:26 DOI 10.1186/s12879-016-2144-4 RESEARCH ARTICLE Open Access Strain-specific transmission in an outbreak of ESBL-producing Enterobacteriaceae in the hemato-oncology

More information

Extended-Spectrum -Lactamases: a Clinical Update

Extended-Spectrum -Lactamases: a Clinical Update CLINICAL MICROBIOLOGY REVIEWS, Oct. 2005, p. 657 686 Vol. 18, No. 4 0893-8512/05/$08.00 0 doi:10.1128/cmr.18.4.657 686.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved. Extended-Spectrum

More information

The revolving door between hospital and community: extended-spectrum beta-lactamaseproducing Escherichia coli in Dublin.

The revolving door between hospital and community: extended-spectrum beta-lactamaseproducing Escherichia coli in Dublin. Royal College of Surgeons in Ireland e-publications@rcsi Clinical Microbiology Articles Department of Clinical Microbiology 1-7-2012 The revolving door between hospital and community: extended-spectrum

More information

Activity of Ceftolozane/Tazobactam Against a Broad Spectrum of Recent Clinical Anaerobic Isolates

Activity of Ceftolozane/Tazobactam Against a Broad Spectrum of Recent Clinical Anaerobic Isolates AAC Accepts, published online ahead of print on 25 November 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.02253-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. Activity

More information

Phenotypic detection of ESBLs and carbapenemases

Phenotypic detection of ESBLs and carbapenemases Phenotypic detection of ESBLs and carbapenemases Standardized susceptibility testing residential workshop 2016 Katie Hopkins PhD Clinical Scientist Antimicrobial Resistance and Healthcare Associated Infections

More information

A Snapshot of Colistin Use in South-East Europe and Particularly in Greece

A Snapshot of Colistin Use in South-East Europe and Particularly in Greece A Snapshot of Colistin Use in South-East Europe and Particularly in Greece Helen Giamarellou 02.05.2013 When Greek Physicians Prescribe Colistin? It is mainly prescribed in the ICU for VAP, bacteremia

More information

Diagnosis of CPE: time to throw away those agar plates? Jon Otter, PhD FRCPath Guy s and St. Thomas NHS Foundation Trust / King s College London

Diagnosis of CPE: time to throw away those agar plates? Jon Otter, PhD FRCPath Guy s and St. Thomas NHS Foundation Trust / King s College London Diagnosis of CPE: time to throw away those agar plates? Jon Otter, PhD FRCPath Guy s and St. Thomas NHS Foundation Trust / King s College London Disclosures I am employed part-time by Bioquell I have research

More information

Enterobacter aerogenes

Enterobacter aerogenes Enterobacter aerogenes Piagnerelli M 1, Carlier E 1, Deplano A 3, Lejeune P 1, Govaerts D 2 1 Departments of Intensive Care and 2 Microbiology, A. Vésale Hospital. 6110 Montigny-le-Tilleul. 3 Department

More information

Guidelines. 14 Nov Marc Bonten

Guidelines. 14 Nov Marc Bonten Guidelines 14 Nov 2014 Marc Bonten Treatment of Community-Acquired Pneumonia SWAB/ NVALT guideline 2011, replaced SWAB guideline 2005 Empirical treatment must cover the most likely causative pathogen.

More information

PREVENTIVE MEDICINE - LABORATORY

PREVENTIVE MEDICINE - LABORATORY Rev. Med. Chir. Soc. Med. Nat., Iaşi 2014 vol. 118, no. 3 PREVENTIVE MEDICINE - LABORATORY ORIGINAL PAPERS CLINICAL EPIDEMIOLOGICAL STUDY ON THE INCIDENCE OF ESCHERICHIA COLI INFECTIONS IN THE CANCER PATIENTS

More information

ORIGINAL ARTICLE SUSCEPTIBILITY PATTERNS IN GRAM NEGATIVE URINARY ISOLATES TO CIPROFLOXACIN, CO-TRIMOXAZOLE AND NITROFURANTOIN

ORIGINAL ARTICLE SUSCEPTIBILITY PATTERNS IN GRAM NEGATIVE URINARY ISOLATES TO CIPROFLOXACIN, CO-TRIMOXAZOLE AND NITROFURANTOIN SUSCEPTIBILITY PATTERNS IN GRAM NEGATIVE URINARY ISOLATES TO CIPROFLOXACIN, CO-TRIMOXAZOLE AND NITROFURANTOIN Anoop Sinha 1, Benny P V 2 HOW TO CITE THIS ARTICLE: Anoop Sinha, Benny PV. Susceptibility

More information

Antibiotic resistance in bacteria from outpatients

Antibiotic resistance in bacteria from outpatients Antibiotic resistance in bacteria from outpatients In France Vincent Jarlier Bacteriology-Hygiene Pitié-Salpêtrière hospital, Paris ONERBA : non profit organization supported by AFSSAPS (French drug agency)

More information

Treatment Options for Urinary Tract Infections Caused by Extended-Spectrum Β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae

Treatment Options for Urinary Tract Infections Caused by Extended-Spectrum Β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Treatment Options for Urinary Tract Infections Caused by Extended-Spectrum Β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae medicine.missouri.edu/jahm/treatment-options-urinary-tract-infections-caused-extended-spectrum-β-lactamase-producingescherichia-coli-klebsiella-pneumoniae/

More information

Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis

Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis J Antimicrob Chemother 2016; 71: 2563 2568 doi:10.1093/jac/dkw178 Advance Access publication 30 May 2016 Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis Justin

More information

CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE

CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE Veroniek Saegeman Veroniek Saegeman UZLeuven Carbapenemase producing Enterobacteriaceae (CPE) Introduction on antibiotic resistance Classification of ß-lactamases

More information

Outcomes in UK patients with hospital-acquired bacteraemia and the risk of catheter-associated urinary tract infections

Outcomes in UK patients with hospital-acquired bacteraemia and the risk of catheter-associated urinary tract infections 1 Department of Infection, Barts Health NHS Trust, Royal London Hospital, London, UK 2 Department of Primary Care and Population Health, University College London, London, UK Correspondence to Dr Mark

More information

Chapter 2. Detection of ESBL producing Enterobacteriaceae

Chapter 2. Detection of ESBL producing Enterobacteriaceae Chapter 2 Detection of ESBL producing Enterobacteriaceae Chapter 1 22 Chapter 2.1 Laboratory detection of extended-spectrum β-lactamase-producing Enterobacteriaceae: evaluation of two screening agar plates

More information

UTI can affect lower and sometimes both lower and upper urinary tracts. The term cystitis has been used to define the lower UTI infection and is

UTI can affect lower and sometimes both lower and upper urinary tracts. The term cystitis has been used to define the lower UTI infection and is 1. INTRODUCTION Infectious disease is a clinically evident condition that results from a pathogenic agent which includes bacteria, fungi, virus, protozoa, multi-cellular parasites and aberrant proteins

More information

by author ESCMID Online Lecture Library

by author ESCMID Online Lecture Library The Karyatides at the Erechtheion Temple Devoted to the Women in the Audience At the top of the Museum the Karyatides, watching you through the years to come FOSFOMYCIN IN THE TREATMENT OF INFECTIONS

More information

Nosocomial infections surveillance in RIPAS Hospital

Nosocomial infections surveillance in RIPAS Hospital Original Article Brunei Int Med J. 212; 8 (6): 32-333 Nosocomial infections surveillance in RIPAS Hospital Muppidi SATYAVANI, 1, 2 Junita MOMIN, ² and Samuel Kai San YAPP 2, 3 ¹ Department of Microbiology,

More information

ALERT. Clinical microbiology considerations related to the emergence of. New Delhi metallo beta lactamases (NDM 1) and Klebsiella

ALERT. Clinical microbiology considerations related to the emergence of. New Delhi metallo beta lactamases (NDM 1) and Klebsiella ALERT Clinical microbiology considerations related to the emergence of New Delhi metallo beta lactamases (NDM 1) and Klebsiella pneumoniae carbapenemases (KPC) amongst hospitalized patients in South Africa

More information

bla TEM bla CTX-M محمد مرتضي اردوني Extended-spectrum beta-lactamases ESBL Avian pathogenic Escherichia coli ESBLs (ESBLs)

bla TEM bla CTX-M محمد مرتضي اردوني Extended-spectrum beta-lactamases ESBL Avian pathogenic Escherichia coli ESBLs (ESBLs) bla bla -M 2 محمد مرتضي اردوني () -M ESBL bla bla -M -M bla bla -M Extended-spectrum beta-lactamases ESBL bla bla -M Avian pathogenic AEC Escherichia coli پست الکترونيک نويسندهي مسؤول: mjahantig@yahoo.com

More information

#Corresponding author: Pathology Department, Singapore General Hospital, 20 College. Road, Academia, Level 7, Diagnostics Tower, , Singapore

#Corresponding author: Pathology Department, Singapore General Hospital, 20 College. Road, Academia, Level 7, Diagnostics Tower, , Singapore AAC Accepts, published online ahead of print on 21 October 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.01754-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 Title: Escherichia

More information

Burns outbreaks - the UHB experience

Burns outbreaks - the UHB experience Burns outbreaks - the UHB experience Dr Mark Garvey Mr Craig Bradley Principal Clinical Scientist in Microbiology Lead Nurse Infection Prevention Director of the Hospital Infection Research Laboratory

More information

Translocation Studies Mid-Term Review (MTR) Meeting Marseille, France

Translocation Studies Mid-Term Review (MTR) Meeting Marseille, France Marie Curie Actions Research Training Networks (RTN) Translocation Studies Mid-Term Review (MTR) Meeting Marseille, France F. Vidal-Aroca, M.G.P. Page and J. Dreier Background Deteriorating situation regarding

More information